BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27464521)

  • 1. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
    Basudhar D; Somasundaram V; de Oliveira GA; Kesarwala A; Heinecke JL; Cheng RY; Glynn SA; Ambs S; Wink DA; Ridnour LA
    Antioxid Redox Signal; 2017 Jun; 26(18):1044-1058. PubMed ID: 27464521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
    Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
    Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
    Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.
    Ambs S; Glynn SA
    Cell Cycle; 2011 Feb; 10(4):619-24. PubMed ID: 21293193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOS2 as an Emergent Player in Progression of Cancer.
    Thomas DD; Wink DA
    Antioxid Redox Signal; 2017 Jun; 26(17):963-965. PubMed ID: 28506076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
    Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism.
    Somasundaram V; Basudhar D; Bharadwaj G; No JH; Ridnour LA; Cheng RYS; Fujita M; Thomas DD; Anderson SK; McVicar DW; Wink DA
    Antioxid Redox Signal; 2019 Mar; 30(8):1124-1143. PubMed ID: 29634348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis.
    Burke AJ; Garrido P; Johnson C; Sullivan FJ; Glynn SA
    Antioxid Redox Signal; 2017 Jun; 26(18):1078-1090. PubMed ID: 28326819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.
    de Oliveira GA; Cheng RYS; Ridnour LA; Basudhar D; Somasundaram V; McVicar DW; Monteiro HP; Wink DA
    Antioxid Redox Signal; 2017 Jun; 26(18):1059-1077. PubMed ID: 27494631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage NOS2 in Tumor Leukocytes.
    Brüne B; Courtial N; Dehne N; Syed SN; Weigert A
    Antioxid Redox Signal; 2017 Jun; 26(18):1023-1043. PubMed ID: 27397579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Peptidylarginine Deiminase Inhibitor Cl-Amidine Suppresses Inducible Nitric Oxide Synthase Expression in Dendritic Cells.
    Jang B; Ishigami A; Kim YS; Choi EK
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
    Glynn SA; Boersma BJ; Dorsey TH; Yi M; Yfantis HG; Ridnour LA; Martin DN; Switzer CH; Hudson RS; Wink DA; Lee DH; Stephens RM; Ambs S
    J Clin Invest; 2010 Nov; 120(11):3843-54. PubMed ID: 20978357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways.
    Sheta EA; Trout H; Gildea JJ; Harding MA; Theodorescu D
    Oncogene; 2001 Nov; 20(52):7624-34. PubMed ID: 11753640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level.
    Somasundaram V; Gilmore AC; Basudhar D; Palmieri EM; Scheiblin DA; Heinz WF; Cheng RYS; Ridnour LA; Altan-Bonnet G; Lockett SJ; McVicar DW; Wink DA
    Redox Biol; 2020 Jan; 28():101354. PubMed ID: 31683257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO
    Wang J; Hussain SP
    Antioxid Redox Signal; 2017 Jun; 26(17):1000-1008. PubMed ID: 27510096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors.
    Mohan S; Patel S; Barlow D; Rojas AC
    Adv Med Sci; 2020 Sep; 65(2):424-428. PubMed ID: 32919119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
    Jung WK; Choi I; Lee DY; Yea SS; Choi YH; Kim MM; Park SG; Seo SK; Lee SW; Lee CM; Park YM; Choi IW
    Int J Biochem Cell Biol; 2008; 40(11):2572-82. PubMed ID: 18571461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-Nitrosylation of Ras Mediates Nitric Oxide-Dependent Post-Injury Neurogenesis in a Seizure Model.
    Santos AI; Carreira BP; Izquierdo-Álvarez A; Ramos E; Lourenço AS; Filipa Santos D; Morte MI; Ribeiro LF; Marreiros A; Sánchez-López N; Marina A; Carvalho CM; Martínez-Ruiz A; Araújo IM
    Antioxid Redox Signal; 2018 Jan; 28(1):15-30. PubMed ID: 28648093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide induces inducible nitric oxide synthase-dependent podocyte dysfunction via a hypoxia-inducible factor 1α and cell division control protein 42 and Ras-related C3 botulinum toxin substrate 1 pathway.
    Mashmoushi AK; Oates JC
    Free Radic Biol Med; 2015 Jul; 84():185-195. PubMed ID: 25765888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
    Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
    Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.